ByteDance completes $290 million fundraising for AI drug unit
ByteDance has completed a $290 million fundraising for its AI drugmaking unit, sources said, after spinning the unit off from the group.
ByteDance has completed a $290 million fundraising for its AI drugmaking unit after spinning it off from the group, according to two people with knowledge of the matter. The Shanghai-headquartered Anew Labs uses AI for drug discovery.